1. Home
  2. FF vs ABEO Comparison

FF vs ABEO Comparison

Compare FF & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FutureFuel Corp.

FF

FutureFuel Corp.

HOLD

Current Price

$3.38

Market Cap

141.5M

Sector

Industrials

ML Signal

HOLD

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$5.36

Market Cap

281.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FF
ABEO
Founded
N/A
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
141.5M
281.0M
IPO Year
N/A
1980

Fundamental Metrics

Financial Performance
Metric
FF
ABEO
Price
$3.38
$5.36
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$18.20
AVG Volume (30 Days)
208.2K
1.6M
Earning Date
11-10-2025
11-12-2025
Dividend Yield
7.12%
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.29
Revenue
$137,409,000.00
$400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1,590.36
P/E Ratio
N/A
$4.17
Revenue Growth
N/A
N/A
52 Week Low
$3.09
$3.93
52 Week High
$5.78
$7.54

Technical Indicators

Market Signals
Indicator
FF
ABEO
Relative Strength Index (RSI) 50.22 59.34
Support Level $3.15 $4.53
Resistance Level $3.49 $5.61
Average True Range (ATR) 0.11 0.26
MACD 0.04 0.11
Stochastic Oscillator 77.92 78.90

Price Performance

Historical Comparison
FF
ABEO

About FF FutureFuel Corp.

FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuel segment sells biodiesel and other petroleum products. Its fuels are made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment sells products that are used in the production of agricultural chemicals, which include herbicides, coatings, and cleaning products, such as detergents.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: